Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Peptide-based treatment for autoimmune diseases: learning how to handle a double-edged sword.

Literature DB >> 12727917

Peptide-based treatment for autoimmune diseases: learning how to handle a double-edged sword.

Alberto Pugliese¹.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2003 PMID： 12727917 PMCID： PMC154453 DOI： 10.1172/JCI18395

Source DB: PubMed Journal: J Clin Invest ISSN： 0021-9738 Impact factor: 14.808

× No keyword cloud information.

20 in total

1. Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library.

Authors: F S Wong; J Karttunen; C Dumont; L Wen; I Visintin; I M Pilip; N Shastri; E G Pamer; C A Janeway
Journal: Nat Med Date: 1999-09 Impact factor: 53.440

2. Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy.

Authors: M A Atkinson; N K Maclaren; R Luchetta
Journal: Diabetes Date: 1990-08 Impact factor: 9.461

Review 3. Antigen-specific immunotherapy: oral tolerance and subcutaneous immunization in the treatment of insulin-dependent diabetes.

Authors: A Muir; D Schatz; N Maclaren
Journal: Diabetes Metab Rev Date: 1993-12

4. Oral administration of insulin to neonates suppresses spontaneous and cyclophosphamide induced diabetes in the NOD mouse.

Authors: R Maron; M Guerau-de-Arellano; X Zhang; H L Weiner
Journal: J Autoimmun Date: 2001-02 Impact factor: 7.094

5. Retardation or acceleration of diabetes in NOD/Lt mice mediated by intrathymic administration of candidate beta-cell antigens.

Authors: M Cetkovic-Cvrlje; I C Gerling; A Muir; M A Atkinson; J F Elliott; E H Leiter
Journal: Diabetes Date: 1997-12 Impact factor: 9.461

6. Aerosol insulin induces regulatory CD8 gamma delta T cells that prevent murine insulin-dependent diabetes.

Authors: L C Harrison; M Dempsey-Collier; D R Kramer; K Takahashi
Journal: J Exp Med Date: 1996-12-01 Impact factor: 14.307

7. Similar peptides from two beta cell autoantigens, proinsulin and glutamic acid decarboxylase, stimulate T cells of individuals at risk for insulin-dependent diabetes.

Authors: G Rudy; N Stone; L C Harrison; P G Colman; P McNair; V Brusic; M B French; M C Honeyman; B Tait; A M Lew
Journal: Mol Med Date: 1995-09 Impact factor: 6.354

8. Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23).

Authors: D Daniel; D R Wegmann
Journal: Proc Natl Acad Sci U S A Date: 1996-01-23 Impact factor: 11.205

9. Oral administration of human insulin to NOD mice generates CD4+ T cells that suppress adoptive transfer of diabetes.

Authors: I Bergerot; N Fabien; V Maguer; C Thivolet
Journal: J Autoimmun Date: 1994-10 Impact factor: 7.094

10. Severe anaphylactic reactions to glutamic acid decarboxylase (GAD) self peptides in NOD mice that spontaneously develop autoimmune type 1 diabetes mellitus.

Authors: Rosetta Pedotti; Maija Sanna; Mindy Tsai; Jason DeVoss; Lawrence Steinman; Hugh McDevitt; Stephen J Galli
Journal: BMC Immunol Date: 2003-02-22 Impact factor: 3.615

6 in total

Peptide-based treatment for autoimmune diseases: learning how to handle a double-edged sword.

1. Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library.

2. Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy.

Review 3. Antigen-specific immunotherapy: oral tolerance and subcutaneous immunization in the treatment of insulin-dependent diabetes.

4. Oral administration of insulin to neonates suppresses spontaneous and cyclophosphamide induced diabetes in the NOD mouse.

5. Retardation or acceleration of diabetes in NOD/Lt mice mediated by intrathymic administration of candidate beta-cell antigens.

6. Aerosol insulin induces regulatory CD8 gamma delta T cells that prevent murine insulin-dependent diabetes.

7. Similar peptides from two beta cell autoantigens, proinsulin and glutamic acid decarboxylase, stimulate T cells of individuals at risk for insulin-dependent diabetes.

8. Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23).

9. Oral administration of human insulin to NOD mice generates CD4+ T cells that suppress adoptive transfer of diabetes.

10. Severe anaphylactic reactions to glutamic acid decarboxylase (GAD) self peptides in NOD mice that spontaneously develop autoimmune type 1 diabetes mellitus.

Review 1. Relative paradigms between autoantibodies in lupus and autoantibodies in cancer.

Review 2. Targeting T lymphocytes for immune monitoring and intervention in autoimmune diabetes.

Review 3. Interventions for latent autoimmune diabetes (LADA) in adults.

4. Generation of gene-engineered chimeric DNA molecules for specific therapy of autoimmune diseases.

Review 5. Autoantibodies to tumor-associated antigens: reporters from the immune system.

6. Antigen-based immune therapeutics for type 1 diabetes: magic bullets or ordinary blanks?